Mumbai City FC announces Ultrahuman as the club’s Official Wearable Partner for the upcoming ISL 2024-25 Season. This partnership marks a significant step in enhancing player performance and well-being through its cutting-edge technology.
Ultrahuman is a pioneer in wearable technology. By collating a large set of biomarkers on an integrated platform, Ultrahuman creates a grand unified view of the human body.
Mumbai City FC players will use the Ultrahuman Ring AIR, the world's lightest smart ring, to help improve their training, matchday performance and recovery.
The Ring AIR is a part of the Ultrahuman ecosystem that also has Ultrahuman M1, a continuous glucose monitoring platform; Blood Vision, a preventive blood testing platform with the pioneering UltraTrace™ technology; and Ultrahuman Home, a revolutionary health device for your home.
Ring AIR will provide insights that enable the players to sustain endurance and maintain energy levels during a match while providing a detailed breakdown of sufficient deep, NREM, and REM sleep, which is vital for the players' rest and recovery protocols. Understanding the athletes' performance and recovery enhances their physical endurance and cognition by monitoring indicators such as sleep, stress, movement, heart rate (HR), heart rate variability (HRV), and skin temperature.
Kandarp Chandra – CEO, Mumbai City, Commented:
"Joining hands with Ultrahuman - a pioneer in health technology - is an exciting moment for us. Their evolution through innovation in the health tracking and wearables space will help our players optimize their training and recovery. This aligns with Mumbai City FC’s mission to prioritize player well-being thus laying the foundation for excellence in performance. We look forward to a successful partnership that elevates our team and brings our fans the best football we can play."
Founder and CEO of Ultrahuman, Mohit Kumar, said,
"We are thrilled to partner with the most successful team in Indian Super League (ISL) history. With the Ring AIR, players and coaches will benefit from advanced insights derived from powerful biomarkers to support their performance, cognition and recovery."
